Clinical Trial Update: Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial assessing perifosine with bortezomib and dexamethasone in multiple myeloma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Multiple Myeloma | Phase 3 | Status: TERMINATED